英派药业致力于研发具有自主知识产权的靶向抗癌创新药，专注于合成致死作用机制。公司以DNA损伤修复通路（DDR）自主研发产品为基础，构建了全球生物医药公司中覆盖面最广的DDR产品组合之一，并且正在逐步拓展到更多的全新的合成致死靶点。
Location: China, Shanghai, Pudong
Employees: 51-200
Total raised: $40M
Founded date: 2009
Investors 1
| Date | Name | Website |
| - | West Fount... | westfounta... |
Funding Rounds 2
| Date | Series | Amount | Investors |
| 03.08.2018 | Series C | $30M | - |
| 22.02.2016 | Series B | $10M | - |
Mentions in press and media 9
| Date | Title | Description | Source |
| 22.04.2024 | Deals in brief: Temasek Trust entities fund five startups un... | NewsDeals in brief: Jago Coffee raises USD 6 million in Series A round, Levelup merges with Zevero, ... | kr-asia.co... |
| 01.06.2023 | Impact Therapeutics Entered into Global Partnership with Eik... | SHANGHAI and HAYWARD, Calif., June 1, 2023 /PRNewswire/ -- IMPACT Therapeutics ("Impact"),... | en.prnasia... |
| 14.03.2022 | Impact Therapeutics Closes Series D1 Financing | Impact Therapeutics, a Shanghai, China-based biopharmaceutical company, raised an undisclosed amount... | finsmes.co... |
| 14.03.2022 | Impact Therapeutics Announces Completion of Series D1 Financ... | SHANGHAI, March 14, 2022 /PRNewswire/ -- IMPACT Therapeutics, a biopharmaceutical company dedicated ... | en.prnasia... |
| 06.12.2021 | IMPACT 2021 R&D Day: Synthetic Lethality Provides a New ... | SHANGHAI, Dec. 6, 2021 /PRNewswire/ -- The 2nd R&D Day event of IMPACT Therapeutics (IMPACT) suc... | en.prnasia... |
| 03.12.2020 | News briefing: New senescent cell play launches with $12M... | The idea of targeting senescent cells to treat age-related diseases is continuing to gathe... | endpts.com... |
| 07.08.2018 | Impact Therapeutics raises $30m in Decheng Capital-led Serie... | Premium Chinese biopharmaceutical startup IMPACT Therapeutics has raised $30 million in a Series C r... | dealstreet... |
| 03.08.2018 | Impact Therapeutics Raises $30M In Series C Financing | Impact Therapeutics, Inc., a Nanjing, China-based clinical-stage biopharmaceutical company dedicated... | finsmes.co... |
| 22.02.2016 | Impact Therapeutics Secures $10M in Series B Funding | Impact Therapeutics, a Nanjing, China-based company dedicated to the discovery, development and comm... | finsmes.co... |